Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
MONTREAL, Aug. 1, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the “Company”) will announce its second quarter 2013 financial and operating results after market close on Thursday, August 8, 2013. The Company will host a conference call to discuss these results on Friday, August 9, 2013, at 8:30 a.m., Eastern Time.
Participants may access the live webcast via the Company’s website at www.aezsinc.com in the “Newsroom” section, or by telephone using the following numbers: in Canada, 514-807-9895 or 647-427-7450, outside Canada, 888-231-8191. A replay of the webcast will also be available on the Company’s website for a period of 30 days.
About Aeterna Zentaris
Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. The Company’s pipeline encompasses compounds from drug discovery to regulatory approval. For more information, visit www.aezsinc.com.
SOURCE Aeterna Zentaris Inc.
Help employers find you! Check out all the jobs and post your resume.
